Concepedia
Statistics
Publications
6
Citations
705
H-Index
Active since
2017
Affiliations
City of Hope(Current)
Beckman Research Institute
University of California, Los Angeles
City Of Hope National Medical Center
University of Southern California
Dileshni Tilakawardane is an author at City of Hope specializing in urology, cancer therapeutics, and tumor immunity.
Top concepts
UrologyMedicineOncologyImmunologyImmunotherapyCancer TherapyTumor ImmunityRadiation OncologyTumor Microenvironment
Publications per year
2017–2024
Regional Delivery of Chimeric Antigen Receptor–Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain
Saul J. Priceman, Dileshni Tilakawardane, Brook Jeang et al. · Clinical Cancer Research · 2017 · 313 citations · Full text
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
Saul J. Priceman, Ethan Gerdts, Dileshni Tilakawardane et al. · OncoImmunology · 2017 · 162 citations · Full text
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity
John P. Murad, Dileshni Tilakawardane, Anthony K. Park et al. · Molecular Therapy · 2021 · 101 citations · Full text
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial
Tanya B. Dorff, M. Suzette Blanchard, Lauren Adkins et al. · Nature Medicine · 2024 · 92 citations · Full text
Chimeric Antigen Receptor, Car T Cells, Urology +14
Effective Combination Immunotherapy using Oncolytic Viruses to Deliver CAR Targets to Solid Tumors
Anthony K. Park, Yuman Fong, Nanhai G. Chen et al. · 2019 · 23 citations · Full text
1–5 of 6